Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 4,500 shares at $159.91 ($720K) on 2018-08-14, disclosed to the SEC on 2018-08-15.
Open-market sale of $720k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.08 | 600 | $95K | 13.3% |
| 2 | $159.91 | 3,199 | $512K | 71.1% |
| 3 | $160.70 | 701 | $113K | 15.7% |
| Total | $159.92 avg | 4,500 | $720K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |